MARKET

HSTO

HSTO

Histogen Inc
EXMKT
0.315
-0.005
-1.56%
Closed 13:47 02/23 EST
OPEN
0.315
PREV CLOSE
0.320
HIGH
0.315
LOW
0.315
VOLUME
227
TURNOVER
72
52 WEEK HIGH
1.630
52 WEEK LOW
0.280
MARKET CAP
1.35M
P/E (TTM)
-0.1088
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at HSTO last week (0212-0216)?
Weekly Report · 5d ago
Weekly Report: what happened at HSTO last week (0205-0209)?
Weekly Report · 02/12 11:52
Weekly Report: what happened at HSTO last week (0129-0202)?
Weekly Report · 02/05 12:04
Weekly Report: what happened at HSTO last week (0122-0126)?
Weekly Report · 01/29 11:49
Weekly Report: what happened at HSTO last week (0115-0119)?
Weekly Report · 01/22 11:54
Weekly Report: what happened at HSTO last week (0108-0112)?
Weekly Report · 01/15 11:49
Weekly Report: what happened at HSTO last week (0101-0105)?
Weekly Report · 01/08 11:54
Weekly Report: what happened at HSTO last week (1225-1229)?
Weekly Report · 01/01 11:47
More
About HSTO
Histogen Inc. is a clinical-stage therapeutics company. The Company is focused on developing clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body’s natural process to restore immune function. Its product candidates include emricasan, CTS-2090 and CTS-2096. It develops emricasan for acute bacterial skin and skin structure infections (ABSSSI) as well evaluating its use for other infectious diseases. Its pipeline also includes novel preclinical product candidates including CTS-2090 and CTS-2096, which are selective small molecule inhibitors of caspase-1 designed for the treatment of certain inflammatory diseases. Emricasan is an orally available pan-caspase inhibitor designed to reduce the activities of human caspases, which are enzymes that mediate inflammation and apoptosis. CTS-2090 and CTS-2096 are selective caspase-1 inhibitors targeting inflammasome activation and to treat a variety of inflammation mediated diseases.

Webull offers Histogen Inc stock information, including EXMKT: HSTO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HSTO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HSTO stock methods without spending real money on the virtual paper trading platform.